<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-154689</identifier>
<setSpec>1130-1406</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Update on invasive candidiasis in non-neutropenic critically ill adult patients</dc:title>
<dc:description xml:lang="en">Invasive candidiasis in non-neutropenic critically ill patients remains a challenge for clinicians due to its association with high morbidity and mortality rates, increased incidence, and health-care costs. It is well known that early diagnosis and treatment are associated with a better prognosis. For these reasons a thorough update has been performed in this setting focused on recent Spanish epidemiology, new predictive scores and microbiological tests such as mannan antigen, mannan antibodies, Candida albicans germ-tube antibodies or (1&amp;#8594;3)-&amp;#946;-D-glucan detection, molecular techniques for the detection of fungal-specific DNA, advances in antifungal treatment and educational programs in Spain. An early diagnostic and therapeutic algorithm is proposed based on the combination of scores and microbiological test. The aim of this review is to provide physicians with the best information available in order to improve the prognosis of these patients (AU)</dc:description>
<dc:creator>Pemán, Javier</dc:creator>
<dc:creator>Zaragoza, Rafael</dc:creator>
<dc:creator>Borges, Marcio</dc:creator>
<dc:creator>Ramírez, Paula</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">La candidiasis invasora sigue siendo en la actualidad un reto para el clínico debido a su alta morbimortalidad, el progresivo aumento de su incidencia y los costes asociados. Como bien es sabido, un diagnóstico y tratamiento precoz conlleva un mejor pronóstico. Por todo ello se ha llevado a cabo una minuciosa puesta al día centrada en recientes datos epidemiológicos españoles, nuevos scores predictivos y tests microbiológicos tales como la detección del antígeno manano y de anticuerpos antimanano, anticuerpos antimicelio, (1&amp;#8594;3)-&amp;#946;-D-glucano, técnicas moleculares, avances en el tratamiento antifúngico y programas educacionales en España. El objetivo de esta revisión es dotar al clínico de la mejor información disponible para mejorar el pronóstico de estos pacientes (AU)</dc:description>
<dc:source>Rev Iberoam Micol;33(3): 145-151, jul.-sept. 2016. tab, ilus, graf</dc:source>
<dc:identifier>ibc-154689</dc:identifier>
<dc:title xml:lang="es">Puesta al día en la candidiasis invasora en el paciente crítico no neutropénico</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d24654^s22073</dc:subject>
<dc:subject>^d28612</dc:subject>
<dc:subject>^d29181^s22066</dc:subject>
<dc:subject>^d29181^s22045</dc:subject>
<dc:subject>^d11812</dc:subject>
<dc:subject>^d29181^s22074</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d53933^s22054</dc:subject>
<dc:subject>^d53933^s22012</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d3439^s22045</dc:subject>
<dc:subject>^d53933^s22080</dc:subject>
<dc:subject>^d30170^s22080</dc:subject>
<dc:subject>^d38340</dc:subject>
<dc:subject>^d3439^s22074</dc:subject>
<dc:subject>^d16834</dc:subject>
<dc:subject>^d16843</dc:subject>
<dc:type>article</dc:type>
<dc:date>201609</dc:date>
</metadata>
</record>
</ibecs-document>
